http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CY-1111133-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ffa3f9d6b87e15e0a1551fb129b531
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
filingDate 2010-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bbf5e4c6b0cf0552136fcefc15dff0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12a57dbcd6203e5c3e1892984c79c325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_742ae302b917d2bedd33b19b3cd86c2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0223e191e391bebc3d5e91cf8a67911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b07632a4baddd6b80fcd1c302a0f613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97128c215e65de7684abdf9a4c913db4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d4bdc504501383f2cda9d5327a21abf
publicationDate 2015-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CY-1111133-T1
titleOfInvention EXTRAORDINARY FORMOTEROL PREPARATION
abstract The present invention relates to a medicament for use in the administration of a long-acting inhaled β2-agonist. More particularly, the present invention relates to a chemically stable, highly active HFA formoterol solution to be administered with pMDIs, characterized by a profound penetration into the lung. The invention also relates to methods for the preparation of said formulation and its use in a respiratory disease, such as asthma and chronic obstructive pulmonary disease (COPD).
priorityDate 2002-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3083544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492066

Total number of triples: 46.